# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Aspire Biopharma, Inc. ("Aspire" or the "Company"), a developer of a multi-faceted patent protected disruptive ...
PowerUp Acquisition Corp. (the "Company") (NASDAQ:PWUP) announced today that, on June 3, 2024, the Company received a n...
The business combination is expected to close in the first quarter of 2024